Hello, Guest!
  • Saturday, November 16, 2024

Emergent BioSolutions Books $628M HHS COVID-19 Vaccine Manufacturing Task Order

The Department of Health and Human Services has awarded Gaithersburg, Md.-based biopharmaceutical company Emergent BioSolutions a $628M task order to support the production of potential vaccines for the novel coronavirus through 2021.

HHS said Monday the task order comes as part of Emergent’s existing agreement with the HHS Biomedical Advanced Research and Development Authority and includes $542.8M for contract development and manufacturing organization services for the vaccine candidates.

The award also covers an $85.5M investment to expand Emergent's CDMO activities for therapeutic manufacturing applications.

Contract work is meant to support the Trump administration’s Operation Warp Speed, which seeks to accelerate the production and delivery of candidates for a COVID-19 vaccine.

According to HHS Secretary Alex Azar, Emergent’s manufacturing capacity will help drug companies begin producing doses of their vaccine candidates that are already nearing approval.

“Securing more manufacturing capacity here in America for candidates that make it to the final stages of Operation Warp Speed will help get a vaccine to American patients without a day wasted,” he noted.

In the past two months, BARDA selected pharmaceutical companies AstraZeneca and Moderna to drive the delivery of their respective candidates.

Video of the Day

Related Articles

How the New AI Executive Order Will Impact Government’s AI Landscape Artificial Intelligence

How the New AI Executive Order Will Impact Government’s AI Landscape

President Biden issued a landmark executive order in October that established new standards for artificial intelligence and laid the foundation for AI implementation within the federal government. Deltek Senior Vice President of Information Solutions Kevin Plexico, a Govcon Expert and four-time Wash100 Award winner, spoke with Executive Mosaic about how the executive order will shape the future of AI

American Type Culture Collection Receives $333M HHS Contract to Support Infectious Research Resource Repository Contract Awards

American Type Culture Collection Receives $333M HHS Contract to Support Infectious Research Resource Repository

The Department of Health and Human Services has awarded the nonprofit biological resource center and standards organization American Type Culture Collection a contract with a total value of $333 million to support the Biological and Emerging Infections Research Resources Program. Critical to the work of the National Institute of Allergy and Infectious Diseases, BEI-RRP will

4 Companies Win Spots on $803M HHS Antigen Test Kit Supply Contract Contract Awards

4 Companies Win Spots on $803M HHS Antigen Test Kit Supply Contract

Four companies have won positions on a one-year, $803 million Defense Logistics Agency contract to supply nonprescription rapid antigen test kits for COVID-19 to the Department of Health and Human Services. The Department of Defense on Tuesday listed Access Bio, iHealth Labs, Orasure Technologies and Quidel as holding spots on the firm-fixed-price, indefinite-delivery/indefinite-quantity contract. DLA